Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
Targeted Oncology
|
April 15, 2023
A Multicenter, Phase II Trial of Schedule Modification for Nab-Paclitaxel in Combination with Ramucirumab for Patients with Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer: The B-RAX Trial (JACCRO GC-09)
Ryohei Kawabata, Naoki Izawa, Takahisa Suzuki, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
April 8, 2023
Perioperative TAS-118 plus oxaliplatin in patients with locally advanced gastric cancer: APOLLO-11 study
Daisuke Takahari, Hitoshi Katai, Atsuo Takashima, et al.
Targeted Oncology
|
March 1, 2024
A Phase II Study of FOLFIRI Plus Ziv-Aflibercept After Trifluridine/Tipiracil Plus Bevacizumab in Patients with Metastatic Colorectal Cancer: WJOG 11018G
Toshihiko Matsumoto, Yoshiyuki Yamamoto, Masahito Kotaka, et al.
Targeted Oncology
|
May 6, 2023
A Phase II Trial of Trifluridine/Tipiracil in Combination with Cetuximab Rechallenge in Patients with RAS Wild-Type mCRC Refractory to Prior Anti-EGFR Antibodies: WJOG8916G Trial
Naoki Izawa, Toshiki Masuishi, Naoki Takahashi, et al.
No to Shinkei = Brain and Nerve
|
June 14, 2005
[Significance of shunt efficacy decision of SPECT on idiopathic normal pressure hydrocephalus]
Totaro Takeuchi, Tetsuya Ishihara, Hitoshi Kubo, et al.
Esophagus : Official Journal of the Japan Esophageal Society
|
November 25, 2025
Feasibility of endoscopic response evaluation after induction chemotherapy for determining treatment strategies in esophageal cancer: a post hoc analysis of the CROC trial
Chikatoshi Katada, Tetsuji Yokoyama, Akinori Watanabe, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 5, 2024
Optimizing Organ-Preservation Strategies Through Chemotherapy-Based Selection in Esophageal Squamous Cell Carcinoma: Results From the CROC Multi-Institutional Phase 2 Clinical Trial
Chikatoshi Katada, Tetsuji Yokoyama, Akinori Watanabe, et al.
The Oncologist
|
February 18, 2026
Novel antiemetic effect of naldemedine in patients initiating opioids for cancer pain: A secondary analysis of a randomized clinical trial
Takahiro Higashibata, Takaomi Kessoku, Shinya Kajiura, et al.
Cancer Science
|
October 19, 2020
FMS-like tyrosine kinase 3 (FLT3) amplification in patients with metastatic colorectal cancer
Hiroko Hasegawa, Hiroya Taniguchi, Yoshiaki Nakamura, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2024
Naldemedine for Opioid-Induced Constipation in Patients With Cancer: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial
Jun Hamano, Takahiro Higashibata, Takaomi Kessoku, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
Targeted Oncology
|
April 15, 2023
A Multicenter, Phase II Trial of Schedule Modification for Nab-Paclitaxel in Combination with Ramucirumab for Patients with Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer: The B-RAX Trial (JACCRO GC-09)
Ryohei Kawabata, Naoki Izawa, Takahisa Suzuki, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
April 8, 2023
Perioperative TAS-118 plus oxaliplatin in patients with locally advanced gastric cancer: APOLLO-11 study
Daisuke Takahari, Hitoshi Katai, Atsuo Takashima, et al.
Targeted Oncology
|
March 1, 2024
A Phase II Study of FOLFIRI Plus Ziv-Aflibercept After Trifluridine/Tipiracil Plus Bevacizumab in Patients with Metastatic Colorectal Cancer: WJOG 11018G
Toshihiko Matsumoto, Yoshiyuki Yamamoto, Masahito Kotaka, et al.
Targeted Oncology
|
May 6, 2023
A Phase II Trial of Trifluridine/Tipiracil in Combination with Cetuximab Rechallenge in Patients with RAS Wild-Type mCRC Refractory to Prior Anti-EGFR Antibodies: WJOG8916G Trial
Naoki Izawa, Toshiki Masuishi, Naoki Takahashi, et al.
No to Shinkei = Brain and Nerve
|
June 14, 2005
[Significance of shunt efficacy decision of SPECT on idiopathic normal pressure hydrocephalus]
Totaro Takeuchi, Tetsuya Ishihara, Hitoshi Kubo, et al.
Esophagus : Official Journal of the Japan Esophageal Society
|
November 25, 2025
Feasibility of endoscopic response evaluation after induction chemotherapy for determining treatment strategies in esophageal cancer: a post hoc analysis of the CROC trial
Chikatoshi Katada, Tetsuji Yokoyama, Akinori Watanabe, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 5, 2024
Optimizing Organ-Preservation Strategies Through Chemotherapy-Based Selection in Esophageal Squamous Cell Carcinoma: Results From the CROC Multi-Institutional Phase 2 Clinical Trial
Chikatoshi Katada, Tetsuji Yokoyama, Akinori Watanabe, et al.
The Oncologist
|
February 18, 2026
Novel antiemetic effect of naldemedine in patients initiating opioids for cancer pain: A secondary analysis of a randomized clinical trial
Takahiro Higashibata, Takaomi Kessoku, Shinya Kajiura, et al.
Cancer Science
|
October 19, 2020
FMS-like tyrosine kinase 3 (FLT3) amplification in patients with metastatic colorectal cancer
Hiroko Hasegawa, Hiroya Taniguchi, Yoshiaki Nakamura, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2024
Naldemedine for Opioid-Induced Constipation in Patients With Cancer: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial
Jun Hamano, Takahiro Higashibata, Takaomi Kessoku, et al.
Page
of 7